Visualization of apo B, fibrinogen/fibrin, and fibronectin in the intima of normal human aorta and large arteries and during atherosclerosis

Atherosclerosis

Volumn 82, Issue 3, 1990, Pages 213-226

  Shekhonin, B V ^a   Tararak, E M ^a   Samokhin, G P ^a   Mitkevich, O V ^a   Mazurov, A V ^a   Vinogradov, D V ^a   Vlasik, T N ^a   Kalantarov, G F ^a   Koteliansky, V E ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Apo B; Atherosclerosis; Fibrinogen fibrin; Fibronectin; Immunofluorescence

Indexed keywords

APOLIPOPROTEIN B; FIBRINOGEN; FIBRONECTIN;

AORTA INTIMA; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; FEMALE; FIBRIN DEPOSITION; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; MALE; PRIORITY JOURNAL;

AGED; ANTIBODIES, MONOCLONAL; AORTA; APOLIPOPROTEINS B; ARTERIES; ARTERIOSCLEROSIS; BLOOD PLATELETS; FEMALE; FIBRIN; FIBRINOGEN; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MALE; MIDDLE AGE; VON WILLEBRAND FACTOR;

EID: 0025358256     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(90)90043-I     Document Type: Article

References (43)

1. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture
2. Influence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells
3. Fibrinogen degradation products influence PG-12 synthesis by cultured porcine aortic endothelial and smooth muscle cells
4. Fibrinogen is chemotactic for vascular smooth muscle cells
5. Fibronectin and atherosclerosis
6. Comparative distribution patterns of type I and III collagens and fibronectin in human arteriosclerotic aorta
7. Relative distribution of fibronectin and type I, 111, IV, V collagens in normal and atherosclerotic intima of human arteries
8. Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells
9. Relationship of fibrinogen structure to plasminogen activation and plasmin activity during fibrinolysis
10. Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants in normal and transformed fibroblasts
11. Localization of the cellular- fibronectin-specific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E. coli
12. Monoclonal antibodies that distinguish between human aorta smooth muscle and endothelial cells
13. Distribution of plasma proteins across the human aortic wall. Barrier functions of endothelium and internal elastic lamina
14. Study of the immunohistochemical localization of serum lipoproteins and other plasma proteins in human atherosclerotic lesions
15. Histological and immunofluorescent studies on the evolution of the human atheromatous plaque
16. Localization of low density lipoproteins in arterial lesions from normolipemics employing a purified fluorescentlabeled antibody
17. Immunohistochemical localization of apolipoprotein B in human atherosclerotic lesions
18. Apolipoprotein B accumulation and development of foam cell lesions in coronary arteries of hypercholesterolemic swine
19. Insoluble “fibrin” in human aortic intima. Quantitative studies of the relationship between insoluble “fibrin”, soluble fibrinogen and low density lipoprotein
20. Quantitative studies on fibrinogen and low-density lipoprotein in human aortic intima
21. Immunochemical characterization of fibrinogen, fibrin I and fibrin II in human thrombi and atherosclerotic lesions
22. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies
23. Fibrinolytic activity in human atherosclerotic coronary arteries
24. Distribution and variation of fibrinolytic activity in the walls of human arteries and veins
25. Fibrinolysis and plasminogen concentration in aortic intima in relation to death following myocardial infarction
26. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis
27. Pathogenesis of atherosclerosis
28. The arterial lining
29. Experimental thromboatherosclerosis
30. Aortic plaque morphology in relation to coronary artery
31. Demonstration of fibrin in yellow aortic streaks by the fluorescent antibody technique
32. Infiltration and thrombosis in atherogenesis. A study using immunofluorescent technique
33. Thrombosis and atherosclerosis
34. Atherogenesis and plasma constituents. I. Demonstration of fibrin in the white plaque by the fluorescent antibody technique
35. Repair in arterial tissue. Demonstration of fibrinogen/fibrin in normal and healing rabbit thoracic aorta by the indirect immunoperoxidase technique
36. The survival time of platelets in experimental mural thrombi
37. Infiltration and thrombosis in atherogenesis. A study using immunofluorescent techniques
38. Fibrinogen/fibrin on the surface of macrophages: detection, distribution, binding requirements, and possible role in macrophage adherence phenomena
39. Specific binding of soluble fibrin to macrophages
40. Fibronectin (cold-insoluble globulin). V. Mediation of fibrin-monomer binding to macrophages
41. Absorptive endocytosis of fibrin monomer by macrophages: evidence of receptor for the aminoterminus of the fibrin alpha-chain
42. Human monocytes are associated with the formation of fibrin
43. Binding of fibrinogen to human monocytes